✦ LIBER ✦

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

✍ Scribed by Bronchud, MH; Howell, A; Crowther, D; Hopwood, P; Souza, L; Dexter, TM

Book ID: 109836196
Publisher: Nature Publishing Group
Year: 1989
Tongue: English
Weight: 962 KB
Volume: 60
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1989.234

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of advanced breast cancer with

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony‐stimulating factor

✍ Karin Haider; Gabriela V. Kornek; Werner Kwasny; Georg Weinländer; Julia Valenca 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 86 KB

Phase I study of mitozantrone, methotrex

Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer

✍ O'Brien, MER; Nicolson, M; Montes, A; Tidy, A; Ashley, S; Powles, TJ 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 706 KB

Treatment of advanced, refractory breast

Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor

✍ Werner Kwasny; Gabriela Kornek; Karin Haider; Julia Valencak; Herbert Ulrich-Pur 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 52 KB

Phase I trial of paclitaxel, carboplatin

Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer

✍ John D. Hainsworth; Howard A. Burris III; Lisa H. Morrissey; F. Anthony Greco 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 3 views

## Background: Topotecan is a new antineoplastic agent with a broad spectrum of activity. the purpose of this phase i trial was to define the maximum tolerated dose of topotecan when added to the widely used combination of paclitaxel and carboplatin. ## Methods: Patients with advanced cancer that

The use of colony stimulating factors in

The use of colony stimulating factors in elderly patients with cancer

✍ M. Pietropaolo; W. Gianni; A. Siliscavalli; V. Marigliano; L. Repetto 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Treatment of patients with advanced nons

Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor

✍ Michael Hejna; Gabriela V. Kornek; Markus Raderer; Herbert Ulrich-Pur; Wolfgang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views